The Diabetes Technology & Therapeutics Journal just released a special free supplement covering continuous glucose monitoring. (here) While I haven’t had a chance to read the articles thoroughly, I have perused the titles and abstracts. It looks like I have a lot of reading to do over the next few weeks. One of the articles, “Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control” is by a doctor David Rodbard. We are working with him and another endocrinologist on a project called CADS, short for Computer Assisted Decision Support. A fairly generic name, but the goal is to be able to make medication regime adjustments/suggestions to primary care providers for patients with diabetes based on an automated blood glucose profile. We expect to have the project in beta within the next six months and then it will undergo extensive clinical testing at several military institutions.
Continuous Glucose Monitoring Research and CADS
Advertisement
